Skip to main content

RESMED INC

For the period ended Sep 30, 2026. Filed Oct 30, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Oct 30, 2026

RMD$234.11-0.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Financial Information Financial Statements Condensed Consolidated Balance Sheets (Unaudited)

PART I – FINANCIAL INFORMATIONItem 1

Item 1. Financial Statements

Condensed Consolidated Balance Sheets (Unaudited)

(In US$ and in thousands, except share and per share data)

September 30,2026June 30,2026
Assets
Current assets:
Cash and cash equivalents$1,010,742$1,469,234
Accounts receivable, net of allowances of $27,103 and $25,839 at September 30, 2026 and June 30, 2026, respectively972,4981,036,233
Inventories1,021,358945,805
Prepaid expenses and other current assets504,323416,081
Assets held for sale—457,386
Total current assets3,508,9214,324,739
Non-current assets:
Property, plant and equipment, net601,787581,829
Operating lease right-of-use assets196,688153,167
Goodwill2,908,2322,909,575
Other intangible assets, net442,681452,737
Deferred income taxes344,845329,254
Prepaid taxes and other non-current assets208,657214,649
Total non-current assets4,702,8904,641,211
Total assets$8,211,811$8,965,950
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable$320,677$308,923
Accrued expenses480,166494,921
Operating lease liabilities, current31,52729,141
Deferred revenue171,647162,911
Income taxes payable160,22898,108
Short-term debt, net159,975259,950
Liabilities held for sale—41,156
Total current liabilities1,324,2201,395,110
Non-current liabilities:
Deferred revenue174,209170,951
Deferred income taxes62,65164,640
Operating lease liabilities, non-current169,447137,413
Other long-term liabilities283,965213,028
Long-term debt, net249,629399,415
Total non-current liabilities939,901985,447
Total liabilities2,264,1212,380,557
Commitments and contingencies (Note 10)
Stockholders’ equity:
Preferred stock, $0.01 par value, 2,000,000 shares authorized; none issued——
Common stock, $0.004 par value, 350,000,000 shares authorized; 191,080,699 issued and 140,639,154 outstanding at September 30, 2026 and 191,037,523 issued and 144,239,563 outstanding at June 30, 2026764764
Additional paid-in capital2,133,4182,190,614
Retained earnings7,578,5807,255,121
Treasury stock, at cost, 50,441,545 shares at September 30, 2026 and 46,798,043 shares at June 30, 2026(3,633,335)(2,778,591)
Accumulated other comprehensive loss(131,737)(82,515)
Total stockholders’ equity5,947,6906,585,393
Total liabilities and stockholders’ equity$8,211,811$8,965,950
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.